Abstract: The present invention relates to a conductive paste and a method for producing solar cell by using the same. The conductive paste comprises at least silver powders and a composite glass frit comprising a first type of glass frit containing lead oxides and silicon oxides and a second type of glass frit containing tellurium oxides and zinc oxides wherein the first type of glass frit and the second type of glass frit are in a weight ratio of 93:7 to 44:56.

Abstract: The present invention provides a novel crystalline oxide, a process for producing the crystalline oxides, a conductive paste comprising the crystalline oxides and an article comprising a substrate and an abovementioned conductive paste applied on the substrate.

Abstract: The present invention relates to a conductive paste and a method for producing solar cell by using the same. The conductive paste comprises at least silver powders and a composite glass frit comprising a first type of glass frit containing lead oxides and silicon oxides and a second type of glass frit containing tellurium oxides and zinc oxides wherein the first type of glass frit and the second type of glass frit are in a weight ratio of 93:7 to 44:56.

Abstract: The present invention discloses a conductive paste for solar cell, including the following composition: silver particle and two glass frits. A glass frit (I) comprises bismuth oxide, tellurium oxide, tungsten oxide, silicon oxide, and zinc oxide; and a glass frit (II) comprises lead oxide, tellurium oxide, and zinc oxide. The conductive paste is utilized to form the electrode of the substrate for solar cell to enhance the performance of Ohmic contact, fill factor and conversion efficiency of the solar cell, after sintering.

Abstract: Disclosed are botanical compositions, and more particularly to compositions having particularly beneficial therapeutic or prophylactic properties in a mammal. In particular, the compositions of the present inventions are useful inter alia in the treatment and/or prophylaxis of obesity, overeating, and other eating disorders, as well as an oral supplement in place of, or commensurate with, the consumption of food. The compositions of the present invention may be conveniently formulated for suitable administration, such as, for example, as a dried composition. In particularly preferred embodiments, the compositions of the present invention encompass formulations that comprise, consist essentially of, or consist of, a plurality of at least three herbal plants, horticultural and/or botanical equivalents, and/or extracts thereof, having similar or equivalent medicinal or therapeutic properties.

Abstract: The present invention consists in a method of preparing amino thiohydantoins either in isolation or as the C-terminals residue of a peptide. The method comprises reacting the amino acid or peptide with an acylating agent and thiocyanate or isothiocyanates in the presence of a strong acid. The present invention also relates to an improved method for C-terminal sequencing of peptides which routinely analyses all of the common amino acids of peptides. The invention involves the use of a strong, volatile, anhydrous organic or mineral acid to cleave the terminal amino acid thiohydantoin.

Abstract: The present invention provides peptides and compounds which inhibit the enzyme activity of Type II phospholipases A.sub.2. The preferred compounds are pentapeptides. Where the phospholipase is human Type II phospholipase A.sub.2 the preferred peptides are FLSYK and KFLSY.